Aristotle Capital Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-17,992
| Closed | -$202K | – | 173 |
|
2023
Q3 | $202K | Sell |
17,992
-53
| -0.3% | -$596 | ﹤0.01% | 171 |
|
2023
Q2 | $182K | Sell |
18,045
-51
| -0.3% | -$513 | ﹤0.01% | 171 |
|
2023
Q1 | $170K | Sell |
18,096
-725
| -4% | -$6.82K | ﹤0.01% | 173 |
|
2022
Q4 | $230K | Sell |
18,821
-5,898,680
| -100% | -$72.1M | ﹤0.01% | 176 |
|
2022
Q3 | $73.4M | Sell |
5,917,501
-23,527,520
| -80% | -$292M | 0.16% | 54 |
|
2022
Q2 | $578M | Buy |
29,445,021
+30,384
| +0.1% | +$596K | 1.22% | 39 |
|
2022
Q1 | $767M | Buy |
29,414,637
+203,795
| +0.7% | +$5.32M | 1.4% | 38 |
|
2021
Q4 | $829M | Buy |
29,210,842
+1,027,512
| +4% | +$29.2M | 1.4% | 37 |
|
2021
Q3 | $899M | Buy |
28,183,330
+176,853
| +0.6% | +$5.64M | 1.7% | 31 |
|
2021
Q2 | $972M | Buy |
28,006,477
+383,942
| +1% | +$13.3M | 1.86% | 29 |
|
2021
Q1 | $813M | Buy |
27,622,535
+2,421,880
| +10% | +$71.3M | 1.66% | 32 |
|
2020
Q4 | $773M | Buy |
25,200,655
+1,099,886
| +5% | +$33.7M | 1.92% | 26 |
|
2020
Q3 | $673M | Buy |
24,100,769
+91,350
| +0.4% | +$2.55M | 2.03% | 25 |
|
2020
Q2 | $515M | Buy |
24,009,419
+13,116,783
| +120% | +$281M | 1.73% | 30 |
|
2020
Q1 | $244M | Buy |
+10,892,636
| New | +$244M | 1.03% | 37 |
|